PTAB challenges

Proceedings overview

There has been one AIA trial proceeding filed against US Patent 9516909, which resulted in a discretionary denial of institution. This means that all claims of the patent remain intact and have not been challenged on the merits in an IPR, thereby strengthening the patent's defensive posture for a defendant.

IPR2025-01033 — REVELYST SALES LLC et al. v. ROBERT T. KNIGHT

• Type: Inter Partes Review
• Filed: 2025-07-09
• Status: Discretionary Denial (The PTAB declined to institute the IPR based on procedural grounds, rather than ruling on the merits of the patentability challenge).
• Judge panel: Not publicly available from the search results for the institution decision.
• Petition grounds: The petition challenged claims 1-20 of US Patent 9516909. The specific prior art and statutory bases (e.g., § 102 / § 103) are typically detailed in the institution decision, but the search results indicate a discretionary denial.
• Institution decision: Denied on 2025-12-23. The denial was procedural, indicating the PTAB chose not to institute the review. This often happens for reasons such as a parallel district court litigation advancing faster, or based on the Fintiv factors, although the specific reasoning is not provided in the snippet.
• Final Written Decision: Not applicable, as institution was denied.
• Settlement / termination: Not applicable, as institution was denied.
• Appeal: No appeal to the Federal Circuit was found, likely due to the denial of institution.
• Defensive value: Since institution was denied, all claims (1-20) of US9516909 remain unchallenged by this IPR. For a defendant, this means the patent has not been weakened by this specific PTAB challenge, and a future IPR-based defense would need to navigate the reasoning for the discretionary denial, potentially presenting new arguments or prior art.

Strategic summary

Currently, all claims (1-20) of US Patent 9516909 are SUSTAINED and UNTESTED on the merits through PTAB proceedings. The single IPR filed, IPR2025-01033, resulted in a discretionary denial of institution, meaning the Board did not reach the merits of the patentability challenge. Therefore, no claims have been canceled or found unpatentable through PTAB review.

The estoppel landscape is minimal for future petitioners due to the discretionary denial. Under 35 U.S.C. § 315(e)(2), estoppel only applies to claims for which a final written decision is issued, or where the petitioner raised or could have reasonably raised a ground during a trial that resulted in a final written decision. Since no trial was instituted and no final written decision was issued, the petitioner (REVELYST SALES LLC et al.) and their privies are not formally estopped from raising the same or similar prior art grounds against the patent in subsequent proceedings, although repeated petitions might face further discretionary denials. For a new defendant, most prior-art grounds are still theoretically available for a future PTAB challenge.

Regarding pattern signals, only one IPR has been filed against this patent to date, and it was denied institution. This does not indicate a pattern of aggressive PTAB appeals by the patent owner or involvement of defensive aggregators. However, the presence of ongoing district court litigation (as noted in the "Litigation summary" section) might have influenced the PTAB's discretionary denial, potentially under the Fintiv factors, which consider the advanced stage of parallel litigation.

Recommended next steps

If a defendant is currently facing assertion of US Patent 9516909, it is important to understand that all claims remain intact from a PTAB perspective.

• Review the specific reasoning provided in the PTAB's Decision on Institution for IPR2025-01033 to understand why institution was denied. This decision is crucial for assessing the viability of any future PTAB challenge. The decision should be available on the USPTO PTAB E2E system by searching for IPR2025-01033.
• If considering a new PTAB challenge, analyze the prior art carefully, and develop arguments that address any implicit or explicit concerns raised in the denial decision of IPR2025-01033. Consider whether new prior art or different arguments could lead to a different outcome.
• Given the active district court litigation (8:24-cv-02652 in California Central District Court and 3:26-mc-80147 in California Northern District Court), a defendant should also evaluate how PTAB strategy integrates with the ongoing court proceedings, particularly regarding any potential for a stay of litigation if an IPR were to be instituted.## Proceedings overview
  There has been one AIA trial proceeding filed against US Patent 9516909 (IPR2025-01033), which resulted in a discretionary denial of institution. This means that all claims of the patent remain intact and have not been challenged on the merits in an IPR, thereby strengthening the patent's defensive posture for a defendant.

Proceedings overview

There has been one AIA trial proceeding filed against US Patent 9516909 (IPR2025-01033), which resulted in a discretionary denial of institution. This means that all claims of the patent remain intact and have not been challenged on the merits in an IPR, thereby strengthening the patent's defensive posture for a defendant.

IPR2025-01033 — REVELYST SALES LLC et al. v. ROBERT T. KNIGHT

• Type: Inter Partes Review
• Filed: 2025-07-09
• Status: Discretionary Denial. The PTAB declined to institute the IPR based on procedural grounds rather than ruling on the merits of the patentability challenge.
• Judge panel: The institution decision was issued on 2025-12-23. As of October 20, 2025, USPTO Director John Squires personally makes all institution determinations in IPR and PGR cases, and routine institution decisions are issued as summary notices without written explanations of the reasoning. Therefore, a specific panel of Administrative Patent Judges (APJs) was not assigned to make the institution decision for this IPR.
• Petition grounds: The petition challenged claims 1-20 of US Patent 9516909. Specific prior art and statutory bases (e.g., § 102 / § 103) were likely detailed in the petition, but the discretionary denial means the Board did not assess these on their merits.
• Institution decision: Denied on 2025-12-23. The denial was discretionary, meaning the Director chose not to institute the review. This type of denial often occurs due to factors such as parallel district court litigation or other policy considerations, particularly with the USPTO Director's increased control over institution decisions in late 2025 leading to a significant increase in discretionary denials.
• Final Written Decision: Not applicable, as institution was denied.
• Settlement / termination: Not applicable, as institution was denied.
• Appeal: No appeal to the Federal Circuit was found. Institution decisions are generally final and non-appealable.
• Defensive value: Since institution was denied, all claims (1-20) of US9516909 remain unchallenged by this IPR. For a defendant, this means the patent has not been weakened by this specific PTAB challenge, and a future IPR-based defense would need to address the likely procedural reasons for the discretionary denial, potentially presenting new arguments or prior art.

Strategic summary

Currently, all claims (1-20) of US Patent 9516909 are SUSTAINED and UNTESTED on the merits through PTAB proceedings. The single IPR filed, IPR2025-01033, resulted in a discretionary denial of institution, meaning the Board did not reach the merits of the patentability challenge. Therefore, no claims have been canceled or found unpatentable through PTAB review.

The estoppel landscape is minimal for future petitioners due to the discretionary denial. Under 35 U.S.C. § 315(e)(2), estoppel generally applies where a final written decision is issued, or where the petitioner raised or could have reasonably raised a ground during a trial that resulted in a final written decision. Since no trial was instituted and no final written decision was issued, the petitioner (REVELYST SALES LLC et al.) and their privies are not formally estopped from raising the same or similar prior art grounds against the patent in subsequent proceedings. However, the precedent of discretionary denials, especially under the USPTO Director's increased scrutiny of institution decisions in late 2025, suggests that repeated petitions challenging the same patent might face similar procedural hurdles. For a new defendant, most prior-art grounds are still theoretically available for a future PTAB challenge.

Regarding pattern signals, only one IPR has been filed against this patent to date, and it was denied institution. This does not indicate a pattern of aggressive PTAB appeals by the patent owner or involvement of defensive aggregators. However, the presence of ongoing district court litigation (8:24-cv-02652 in California Central District Court and 3:26-mc-80147 in California Northern District Court) might have influenced the PTAB's discretionary denial. The PTAB often considers the advanced stage of parallel litigation when deciding whether to institute an IPR, particularly under the Fintiv factors.

Recommended next steps

If a defendant is currently facing assertion of US Patent 9516909, it is important to understand that all claims remain intact from a PTAB perspective.

• Review the specific reasoning provided in the PTAB's Decision on Institution for IPR2025-01033. While routine decisions may be summary, any detailed reasoning for the discretionary denial will be crucial for assessing the viability of any future PTAB challenge. The decision should be available on the USPTO's Patent Trial and Appeal Case Tracking System (P-TACTS), which replaced PTAB E2E.
• If considering a new PTAB challenge, analyze the prior art carefully and develop arguments that address any implicit or explicit concerns raised in the denial decision of IPR2025-01033. Consider whether new prior art or different arguments could lead to a different outcome, especially in light of the evolving PTAB institution policies as of late 2025, which have made institution more challenging.
• Given the active district court litigation, a defendant should also evaluate how PTAB strategy integrates with the ongoing court proceedings, particularly regarding any potential for a stay of litigation if an IPR were to be instituted. The recent policy changes at the PTAB, including the proposed rules barring parallel challenges, could impact such strategies.